Category
Baricitinib
CAS Number
1146629-75-5
Molecular Formula
C₁₂H₁₄ClN₃O₂
Molecular Weight
267.71 g/mol
Synonym

(4-Chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl 2,2-dimethylpropanoate ; (4-Chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate;Propanoic acid, 2,2-dimethyl-, (4-chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl ester; (4-Chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl 2,2-dimethylpropanoate; Baricitinib Impurity 6 (Stage-1)

Keywords
Impurities
Metabolites.
Pharmaceutical Standards
Intermediates
Fine Chemicals
slide.1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Baricitinib Impurity 25 is a specified process- or degradation-related impurity that can form during the synthesis or storage of Baricitinib. Like other impurities, it is structurally related to the parent drug and is strictly monitored under pharmaceutical quality guidelines to ensure its levels remain within safe limits, maintaining the drug’s purity, stability, and overall safety.